GYRE — Gyre Therapeutics, Inc.

GYREGyre Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · gyretx.com

5.965USD-1.57%Mkt Cap: 578.29M USDP/E: —Last update: 2026-05-26

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfe…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap578.29M USD

Enterprise Value551.37M USD

Revenue (TTM)117.05M USD

Gross Profit111.17M USD

Net Income (TTM)5.03M USD

Revenue/Share1.292 USD

Last Price5.965 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees625

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)103.00

PEG—

EV/EBITDA108.69

EV/Revenue4.71

P/S5.12

P/B5.57

EPS (TTM)-0.08

EPS (Forward)0.06

52W Range

5.8702% of range11.61

52W High11.61 USD

52W Low5.870 USD

Profitability

Gross Margin95.35%

Oper. Margin-30.21%

EBITDA Margin4.33%

Profit Margin4.31%

ROE4.74%

ROA3.03%

Growth

Revenue Growth2.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF1.01M USD

CapEx (TTM)1.92M USD

FCF Margin8.20%

FCF Yield1.66%

Net Debt-48.98M USD

Net Debt/EBITDA-9.66

Balance Sheet

Debt/Equity0.01

Current Ratio4.64

Quick Ratio3.68

Book Value/Sh1.109 USD

Cash/Share0.5450 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJan 12, 2023

Splits

Last Split1:15

Split DateOct 31, 2023

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)18.67 USD

Target Range18.00 USD – 20.00 USD

# Analysts3

Ownership

Shares Out.97.03M

Float21.28M

Insiders86.33%

Institutions3.75%

Short Interest

Short Ratio26.9d

Short % Float7.64%

Short % Out.1.63%

Shares Short1.58M

Short (prev mo.)1.53M

Technical

SMA 507.293 (-18.2%)

SMA 2007.662 (-22.1%)

Beta5.28

S&P 52W Chg28.31%

Avg Vol (30d)73.48K

Avg Vol (10d)86.68K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—